Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Matthew, Nankivell"'
Autor:
Hannah Simonds, Ruth Langley, Indranil Mallick, Peter Hoskin, Elizabeth Miles, Rozita Abdul Malik, Claire Murphy, Mahesh Parmar, Matthew Nankivell, Jeannette Parkes, Julie Torode, Issa Mohamad, Laurence Edward Court, Isabella Jacques, Mariana Kroiss, Sarbani Laskar, Yolande Lievens, Carol Roach, Barbara Vanderstraeten
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Introduction Fifty per cent of patients with cancer require radiotherapy during their disease course, however, only 10%–40% of patients in low-income and middle-income countries (LMICs) have access to it. A shortfall in specialised workforce has be
Externí odkaz:
https://doaj.org/article/7e143e27867f4edaa860b190a5116af9
Autor:
Avani Athauda, Matthew Nankivell, Rupert Langer, Susan Pritchard, Ruth E. Langley, Katharina von Loga, Naureen Starling, Ian Chau, David Cunningham, Heike I. Grabsch
Publikováno v:
British Journal of Cancer, 128(11), 2036-2043. Nature Publishing Group
Background No definitive largescale data exist evaluating the role of pathologically defined regression changes within the primary tumour and lymph nodes (LN) of resected oesophagogastric (OG) adenocarcinoma following neoadjuvant chemotherapy and the
Autor:
Ruth E Langley, Matthew Nankivell, David Cunningham, Jessica E Ruisch, Heike I. Grabsch, Gayatri Raghuram, William H. Allum, Maximilian Kloft, Jake Emmerson
Publikováno v:
Annals of Surgery, 277(2), e320-e331. LIPPINCOTT WILLIAMS & WILKINS
OBJECTIVE: To analyze the relationship between negative lymph node (LNneg) size as a possible surrogate marker of the host antitumor immune response and overall survival (OS) in esophageal cancer (EC) patients.BACKGROUND: Lymph node (LN) status is a
Autor:
Patrick Tan, Ruth Langley, Matthew Nankivell, Sally Stenning, William Allum, Alicia Okines, Massimo Rugge, Matteo Fassan, Nicola Valeri, Clare Peckitt, Richie Soong, Andrew Wotherspoon, David Cunningham, Shenli Zhang, Elizabeth Smyth
Association between genotype and toxicity Grade 3 or greater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1737d340013d7045780dacbcb63f6226
https://doi.org/10.1158/1078-0432.22461915.v1
https://doi.org/10.1158/1078-0432.22461915.v1
Autor:
Patrick Tan, Ruth Langley, Matthew Nankivell, Sally Stenning, William Allum, Alicia Okines, Massimo Rugge, Matteo Fassan, Nicola Valeri, Clare Peckitt, Richie Soong, Andrew Wotherspoon, David Cunningham, Shenli Zhang, Elizabeth Smyth
Purpose: Germline polymorphisms may affect chemotherapy efficacy and toxicity. We examined the effect of polymorphisms in drug metabolism and DNA repair genes on pathologic response rates, survival, and toxicity for patients randomized to surgery alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdf75ec3254aaaf2de5a69a47378b9a
https://doi.org/10.1158/1078-0432.c.6524952.v1
https://doi.org/10.1158/1078-0432.c.6524952.v1
Autor:
Archie Macnair, Matthew Nankivell, Macey L. Murray, Stuart D. Rosen, Sally Appleyard, Matthew R. Sydes, Sylvia Forcat, Andrew Welland, Noel W. Clarke, Stephen Mangar, Howard Kynaston, Roger Kockelbergh, Abdulla Al-Hasso, John Deighan, John Marshall, Mahesh Parmar, Ruth E. Langley, Duncan C. Gilbert
Publikováno v:
Contemporary Clinical Trials. 128:107162
Autor:
Sophie Merrick, Matthew Nankivell, Matteo Quartagno, Caroline S. Clarke, Nalinie Joharatnam-Hogan, Tom Waddell, Brent O'Carrigan, Michael Seckl, Ehsan Ghorani, Emma Banks, Kim Edmonds, George Bray, Rose Woodward, Rachel Bennett, Jonathan Badrock, Will Hudson, Ruth E. Langley, Naveen Vasudev, Lisa Pickering, Duncan C. Gilbert
Publikováno v:
Contemporary Clinical Trials. 124:107030
Immune checkpoint inhibitors (ICI) have revolutionised treating advanced cancers. ICI are administered intravenously every 2-6 weeks for up to 2 years, until cancer progression/unacceptable toxicity. Physiological efficacy is observed at lower doses
Autor:
Manon Beuque, Derek R. Magee, Avishek Chatterjee, Henry C. Woodruff, Ruth E. Langley, William Allum, Matthew Nankivell, David Cunningham, P. Lambin, Heike I. Grabsch
Publikováno v:
SSRN Electronic Journal.
Autor:
Naureen Starling, David Cunningham, Heike I. Grabsch, William H. Allum, Avani Athauda, Matthew Nankivell, Ian Chau, Ruth E Langley, Derek Alderson
Publikováno v:
European Journal of Cancer, 137, 45-56. ELSEVIER SCI LTD
Background: There is a lack of large-scale randomised data evaluating the impact of sex and age in patients undergoing chemotherapy followed by potentially curative surgery for oesophagogastric cancer. Patients and methods: Individual patient data fr
Autor:
Richard Booton, Matthew Evison, David R Baldwin, Neal Navani, Ian Woolhouse, Lonny Yarmus, Mohammed Munavvar, Andrea Bianco, Syeda Jafri, Sam M. Janes, Mohamed Elshafi, Matthew Nankivell, J.B. Adizie, Usman Maqsood, Fabio Perrotta, Andrew D. Lerner, Keith M. Kerr
Publikováno v:
Chest. 158:1230-1239
Background: Programmed death-ligand 1 (PD-L1) expression on cancer cells is a clinically important biomarker to select patients with non-small cell lung cancer (NSCLC) for treatment with programmed death-1/PD-L1 inhibitors. Clinical trials of immunot